Table 1.
Baseline characteristics of patients
| Protective strategy | Dexrazoxane | Continuous infusion | Crossover |
|---|---|---|---|
| Total Number | 8 | 11 | 10 |
| Age | 25–69 | 24–71 | 23–66 |
| Sex (M/F) | 3/5 | 7/4 | 3/7 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.